BACKGROUND: Controversy exists concerning the influence of gender in the prognosis of patients with heart failure and no evidence is available from specific heart failure clinics. HYPOTHESIS: Women with ambulatory heart failure are managed differently than men, although their prognosis might be better than men. METHODS AND RESULTS: We analyzed the clinical characteristics, complementary test results, treatment, and prognosis in 4720 patients with chronic heart failure seen in 62 specialized clinics forming part of a multicenter registry during a mean follow-up of 40 months. The mean age was 65 +/- 12 years and 71% were men. The men were younger than the women and more often had a history of hyperlipidemia and ischemic heart disease. The men had a more advanced heart failure New York Heart Association (NYHA) functional class (III-IV) than the women and a greater frequency of systolic ventricular dysfunction. The men more often received treatment with beta-blockers, vasodilators, and antiplatelet aggregators as well as higher mean doses as compared with the women. The overall survival after the follow-up was similar for both genders, although the women had lower rates of survival free of admission for heart failure. CONCLUSIONS: Despite the mortality of women and men with heart failure being similar, the rate of readmission for heart failure is greater in women in specialized heart failure clinics. These results may be associated with the pharmacological treatment differences observed. Copyright (c) 2010 Wiley Periodicals, Inc.
BACKGROUND: Controversy exists concerning the influence of gender in the prognosis of patients with heart failure and no evidence is available from specific heart failure clinics. HYPOTHESIS: Women with ambulatory heart failure are managed differently than men, although their prognosis might be better than men. METHODS AND RESULTS: We analyzed the clinical characteristics, complementary test results, treatment, and prognosis in 4720 patients with chronic heart failure seen in 62 specialized clinics forming part of a multicenter registry during a mean follow-up of 40 months. The mean age was 65 +/- 12 years and 71% were men. The men were younger than the women and more often had a history of hyperlipidemia and ischemic heart disease. The men had a more advanced heart failure New York Heart Association (NYHA) functional class (III-IV) than the women and a greater frequency of systolic ventricular dysfunction. The men more often received treatment with beta-blockers, vasodilators, and antiplatelet aggregators as well as higher mean doses as compared with the women. The overall survival after the follow-up was similar for both genders, although the women had lower rates of survival free of admission for heart failure. CONCLUSIONS: Despite the mortality of women and men with heart failure being similar, the rate of readmission for heart failure is greater in women in specialized heart failure clinics. These results may be associated with the pharmacological treatment differences observed. Copyright (c) 2010 Wiley Periodicals, Inc.
Authors: Zhuo Zhao; Hao Wang; Jewell A Jessup; Sarah H Lindsey; Mark C Chappell; Leanne Groban Journal: Am J Physiol Heart Circ Physiol Date: 2014-01-10 Impact factor: 4.733
Authors: Amy Hoang-Kim; Camilla Parpia; Cassandra Freitas; Peter C Austin; Heather J Ross; Harindra C Wijeysundera; Karen Tu; Susanna Mak; Michael E Farkouh; Louise Y Sun; Michael J Schull; Robin Mason; Douglas S Lee; Paula A Rochon Journal: BMC Cardiovasc Disord Date: 2020-05-14 Impact factor: 2.298
Authors: Anyuli Gracia Gutiérrez; Beatriz Poblador-Plou; Alexandra Prados-Torres; Fernando J Ruiz Laiglesia; Antonio Gimeno-Miguel Journal: Int J Environ Res Public Health Date: 2020-03-23 Impact factor: 3.390
Authors: Nicholas R Jones; Andrea K Roalfe; Ibiye Adoki; F D Richard Hobbs; Clare J Taylor Journal: Eur J Heart Fail Date: 2019-09-16 Impact factor: 15.534